Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Etanercept and Venous Thromboembolism: A Case Series
Link ID 23239
Title Etanercept and Venous Thromboembolism: A Case Series
Url http://www.medscape.com/viewarticle/717167?src=rss
Description Three arthritis patients taking Etanercept, an anti-TNF agent, present with deep vein thrombosis (DVT.) Journal of Medical Case Reports
Category Articles > Rheumatology
Keywords
Date Mar 13, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Progress in Spondylarthritis. Spondyloarthritis: Lessons From Imaging
  Can MRI scans provide advanced notice of developing arthritis? Arthritis Research & Therapy
Category:   Articles > Rheumatology


2. Is Long-term Etanercept Therapy Safe and Effective in Patients With Juvenile Rheumatoid Arthritis?
  Juvenile rheumatoid arthritis can be difficult to treat, as not all traditional treatments are effective in patients. Can long-term etanercept therapy provide a safe and effective treatment option?
Nature Clinical Practice Rheumatology
Category:   Articles > Rheumatology


3. Heart Failure More Subtle and Deadly in Rheumatoid Arthritis Patients
  The initial signs and symptoms of heart failure in patients with rheumatoid arthritis (RA) are less obvious than those in patients without RA, and although myocardial function is usually better preserved in RA patients, mortality is higher, new research shows. Reuters Health Information
Category:   Articles > Rheumatology


4. Anti-TNF-Alpha Therapy With Infliximab in Spondyloarthritides
  Do the benefits of anti-TNF therapy in ankylosing spondylitis outweigh the shortcomings of this treatment? Expert Review of Clinical Immunology
Category:   Articles > Rheumatology


5. Traditional Therapy as Effective as Newer Biologics in Early Rheumatoid Arthritis
  Disease-modifying anti-rheumatic drugs are as effective as the biologic agent etanercept plus methotrexate for the treatment of early aggressive rheumatoid arthritis. Medscape Medical News
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS